|
1
|
Jones KB, Salah Z, Del Mare S, et al:
miRNA signatures associate with pathogenesis and progression of
osteosarcoma. Cancer Res. 72:1865–1877. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu JJ, Liu S, Wang JG, et al:
Telangiectatic osteosarcoma: a review of literature. Onco Targets
Ther. 6:593–602. 2013.
|
|
3
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Penna E, Orso F, Cimino D, et al:
microRNA-214 contributes to melanoma tumour progression through
suppression of TFAP2C. EMBO J. 30:1990–2007. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Z and Cai H, Lin L, Tang M and Cai H:
Upregulated expression of microRNA-214 is linked to tumor
progression and adverse prognosis in pediatric osteosarcoma.
Pediatr Blood Cancer. 61:206–210. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou X, Wei M and Wang W: MicroRNA-340
suppresses osteosarcoma tumor growth and metastasis by directly
targeting ROCK1. Biochem Biophys Res Commun. 437:653–658. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miao J, Wu S, Peng Z, Tania M and Zhang C:
MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects.
Tumour Biol. 34:2093–2098. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang H, Kong W, He L, et al: MicroRNA
expression profiling in human ovarian cancer: miR-214 induces cell
survival and cisplatin resistance by targeting PTEN. Cancer Res.
68:425–433. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ueda T, Volinia S, Okumura H, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: a microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Deng M, Ye Q, Qin Z, et al: miR-214
promotes tumorigenesis by targeting lactotransferrin in
nasopharyngeal carcinoma. Tumour Biol. 34:1793–1800. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Duan Q, Wang X, Gong W, et al: ER stress
negatively modulates the expression of the miR-199a/214 cluster to
regulates tumor survival and progression in human hepatocellular
cancer. PLoS One. 7:e315182012. View Article : Google Scholar
|
|
13
|
Shih TC, Tien YJ, Wen CJ, et al:
MicroRNA-214 downregulation contributes to tumor angiogenesis by
inducing secretion of the hepatoma-derived growth factor in human
hepatoma. J Hepatol. 57:584–591. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Derfoul A, Juan AH, Difilippantonio MJ,
Palanisamy N, Ried T and Sartorelli V: Decreased microRNA-214
levels in breast cancer cells coincides with increased cell
proliferation, invasion and accumulation of the Polycomb Ezh2
methyltransferase. Carcinogenesis. 32:1607–1614. 2011. View Article : Google Scholar
|
|
15
|
Qiang R, Wang F, Shi LY, et al: Plexin-B1
is a target of miR-214 in cervical cancer and promotes the growth
and invasion of HeLa cells. Int J Biochem Cell Biol. 43:632–641.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang Z, Chen S, Luan X, et al:
MicroRNA-214 is aberrantly expressed in cervical cancers and
inhibits the growth of HeLa cells. IUBMB Life. 61:1075–1082. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Peng RQ, Wan HY, Li HF, Liu M, Li X and
Tang H: MicroRNA-214 suppresses growth and invasiveness of cervical
cancer cells by targeting
UDP-N-acetyl-alpha-D-galactosamine:polypeptide
N-acetylgalactosaminyltransferase 7. J Biol Chem. 287:14301–14309.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang X, Guo B, Li Q, et al: miR-214
targets ATF4 to inhibit bone formation. Nat Med. 19:93–100. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee YB, Bantounas I, Lee DY, Phylactou L,
Caldwell MA and Uney JB: Twist-1 regulates the miR-199a/214 cluster
during development. Nucleic Acids Res. 37:123–128. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sakurai K, Furukawa C, Haraguchi T, et al:
MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to
generate a double-negative feedback loop in a variety of human
cancers. Cancer Res. 71:1680–1689. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao G, Cai C, Yang T, et al: MicroRNA-221
induces cell survival and cisplatin resistance through PI3K/Akt
pathway in human osteosarcoma. PLoS One. 8:e539062013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guo P, Nie Q, Lan J, Ge J, Qiu Y and Mao
Q: C-Myc negatively controls the tumor suppressor PTEN by
upregulating miR-26a in glioblastoma multiforme cells. Biochem
Biophys Res Commun. 441:186–190. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tian L, Fang YX, Xue JL and Chen JZ: Four
MicroRNAs promote prostate cell proliferation with regulation of
PTEN and its downstream signals in vitro. PLoS One. 8:e758852013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang D, Zhang H, Li M, et al: MicroRNA-124
controls the proliferative, migratory, and inflammatory phenotype
of pulmonary vascular fibroblasts. Circ Res. 114:67–78. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Y, Gao X, Wei F, et al: Diagnostic
and prognostic value of circulating miR-21 for cancer: A systematic
review and meta-analysis. Gene. 533:389–397. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang ZC, Li YY, Wang HY, et al: Knockdown
of miR-214 promotes apoptosis and inhibits cell proliferation in
nasopharyngeal carcinoma. PloS One. 9:e861492014. View Article : Google Scholar : PubMed/NCBI
|
